We value your privacy

We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy

Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Africanian
  • News
  • News 24/7
  • Politics
  • Business
  • Health
  • Sports
  • Travel
  • World
    • US
    • Russia
    • Europe
    • Asia
    • America
  • Events
No Result
View All Result
Africanian
  • News
  • News 24/7
  • Politics
  • Business
  • Health
  • Sports
  • Travel
  • World
    • US
    • Russia
    • Europe
    • Asia
    • America
  • Events
No Result
View All Result
Africanian
No Result
View All Result
Home World Russia

‘The most promising drug against Covid-19 in the world’: Avifavir to be delivered to Russian hospitals in June

Russia's newly approved drug for combating Covid-19 will soon be supplied to the country's hospitals, with the first deliveries expected on June 11. Trials have shown the medication to be highly effective in fighting the virus.

africanian
June 1, 2020
in Russia
1 0
0
'The most promising drug against Covid-19 in the world': Avifavir to be delivered to Russian hospitals in June
Share on FacebookShare on TwitterShare via Whatsapp
On Saturday, the country’s Ministry of Health registered Avifavir, a domestic version of the Japanese drug Favipiravir, which is used against severe forms of influenza. Produced in a joint venture by the Russian Direct Investment Fund (RDIF) and the ChemRar group, the drug could be vitally important in the battle to defeat Covid-19.

“Avifavir is not only the first antiviral drug registered against coronavirus in Russia, but it is also perhaps the most promising drug against Covid-19 in the world,” said Kirill Dmitriev, CEO of the RDIF.

“It was developed and tested in clinical trials in Russia in an unprecedented short period of time, enabling Avifavir to become the first registered drug based on Favipiravir in the world.”

According to the developers, Avifavir disrupts the reproduction mechanisms of Covid-19, and has shown “high efficacy in treating patients with coronavirus during clinical trials.” A study revealed that the virus dies in an average of just four days when a patient takes the drug, compared to nine with a standard course of treatment.

On June 1, the RDIF announced that the 60,000 courses of Avifavir would be delivered to hospitals in Russia this month, with the first expected to arrive on June 11. The drug will not go on sale and will only be used in hospitals under the supervision of a doctor. Avifavir will not be prescribed during pregnancy due to a possible effect on the fetus.

Related Post

Africa battles COVID-19 and 11 other mostly zoonotic disease outbreaks -- Africa CDC

Africa battles COVID-19 and 11 other mostly zoonotic disease outbreaks — Africa CDC

July 26, 2022
COVID-19: South Africa cancels mask mandate, travel certificates

COVID-19: South Africa cancels mask mandate, travel certificates

June 26, 2022

Vaccine-preventable diseases surge in Africa as COVID-19 disrupts vaccination — WHO

May 5, 2022

Health: AstraZeneca Halts Vaccine Jab Production

April 25, 2022

According to the latest official government data, 414,878 people have been diagnosed with Covid-19 in Russia, and 4,855 have died. Compared to the rest of the world, Russia has the third most confirmed coronavirus cases, trailing behind the USA (1,790,191) and Brazil (514,849).

Source: RT
Tags: AvifavirCovid-19Russian hospitals
africanian

africanian

Related Posts

Africa battles COVID-19 and 11 other mostly zoonotic disease outbreaks -- Africa CDC
Health

Africa battles COVID-19 and 11 other mostly zoonotic disease outbreaks — Africa CDC

by africanian
July 26, 2022
COVID-19: South Africa cancels mask mandate, travel certificates
Health

COVID-19: South Africa cancels mask mandate, travel certificates

by africanian
June 26, 2022
Vaccine-preventable diseases surge in Africa as COVID-19 disrupts vaccination -- WHO
Health

Vaccine-preventable diseases surge in Africa as COVID-19 disrupts vaccination — WHO

by africanian
May 5, 2022
No Result
View All Result

Africanian News

Is a dedicated project aimed at amplifying the voices of the African Ecosystem and Diaspora. We actively collaborate with initiatives to improve access to education and digital inclusion, both in traditional schools and through digital platforms, for African children.

It’s crucial to emphasize that none of the articles or images featured on our platform are intended for copyright infringement, neither now nor in the future. If you believe that any information, text, image, etc., may be subject to copyright and should be removed, please notify us by sending an email to info@africanian.com

Your dreams matter; your stories matter.

Feel free to explore collaboration opportunities with us. Share your articles, thoughts, interviews, experiments, or no-comment videos by reaching out to info@africanian.com. You can also subscribe to our mailing list to receive the latest updates from Africanian News.

News letter

© 2025 JNews - Premium WordPress news & magazine theme by Jegtheme.

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Log In

Sign In

Forgot password?

Don't have an account? Register

Forgot password?

Enter your account data and we will send you a link to reset your password.

Back to Login

Your password reset link appears to be invalid or expired.

Log in

Privacy Policy

Accept

Add to Collection

  • Public collection title

  • Private collection title

No Collections

Here you'll find all collections you've created before.

No Result
View All Result
  • News
  • Politics
  • Business
  • Health
  • Sports
  • Entertainment
  • Tech
  • Travel
  • World

© 2025 JNews - Premium WordPress news & magazine theme by Jegtheme.